Unknown

Dataset Information

0

Metabolism-Based Herbicide Resistance to Mesosulfuron-methyl and Identification of Candidate Genes in Bromus japonicus.


ABSTRACT: The evolved resistance of Bromus japonicus Houtt. to ALS-inhibiting herbicides is well established. Previous studies have primarily focused on target-site resistance; however, non-target-site resistance has not been well characterized. This investigation demonstrated that ALS gene sequencing did not detect any previously known resistance mutations in a mesosulfuron-methyl-resistant (MR) population, and notably, treatment with the P450 monooxygenase (P450) inhibitor malathion markedly heightened susceptibility to mesosulfuron-methyl. Utilizing UPLC-MS/MS analysis confirmed elevated mesosulfuron-methyl metabolism in MR plants. The integration of Isoform Sequencing (Iso-Seq) and RNA Sequencing (RNA-Seq) facilitated the identification of candidate genes associated with non-target sites in a subpopulation with two generations of herbicide selection. Through qRT-PCR analysis, 21 differentially expressed genes were characterized, and among these, 10 genes (comprising three P450s, two glutathione S-transferases, one glycosyltransferase, two ATP-binding cassette transporters, one oxidase, and one hydrolase) exhibited constitutive upregulation in resistant plants. Our findings substantiated that increased herbicide metabolism is a driving force behind mesosulfuron-methyl resistance in this B. japonicus population.

SUBMITTER: Li Q 

PROVIDER: S-EPMC11244151 | biostudies-literature | 2024 Jun

REPOSITORIES: biostudies-literature

altmetric image

Publications

Metabolism-Based Herbicide Resistance to Mesosulfuron-methyl and Identification of Candidate Genes in <i>Bromus japonicus</i>.

Li Qi Q   Wang Hengzhi H   Yu Jinping J   Zhang Wei W   Guo Wenlei W   Liu Yixue Y  

Plants (Basel, Switzerland) 20240625 13


The evolved resistance of <i>Bromus japonicus</i> Houtt. to ALS-inhibiting herbicides is well established. Previous studies have primarily focused on target-site resistance; however, non-target-site resistance has not been well characterized. This investigation demonstrated that <i>ALS</i> gene sequencing did not detect any previously known resistance mutations in a mesosulfuron-methyl-resistant (MR) population, and notably, treatment with the P450 monooxygenase (P450) inhibitor malathion marked  ...[more]

Similar Datasets

| S-EPMC11072224 | biostudies-literature
| S-EPMC11682179 | biostudies-literature
| S-EPMC12533250 | biostudies-literature
| S-EPMC7738748 | biostudies-literature